IMRX vs MPC · $124.2M cap vs P/E 16, rev $138.86B
Immuneering Corp (IMRX) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
IMRX currently screens at market cap $124.2M. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the IMRX and MPC stock pages for the full models.
Not investment advice.